萨吉克沙拉的合成和描述来自两个不同的来源:草药和矿物质
Piyush Krantikumar Gandhi1, Rajesh Kundlikrao Ingole1, Ganesh Nigade2
1Department of Rasashastra and Bhaishajya Kalpana, Government Ayurved College Nanded, (Maharashtra), India.
Journal of Ayurveda and integrative medicine
|November 9, 2025
概括
矿物制成的萨吉克沙拉 (Sajjikshara-M) 与植物制成的萨吉克沙拉 (Sajjikshara-H) 相比,具有更高的和碳酸盐含量. 这项比较分析强调了萨吉克沙拉-M作为一种潜在的更强大和更具成本效益的选择.
科学领域:
- 艾尔韦达医学是一种医学.
- 药理学是指药理学,即药理学是指药理学.
- 分析化学是一种分析化学.
背景情况:
- 萨吉克沙拉是一种传统的阿育韦德制剂,来源于草药和矿物来源.
- 目前的标准并没有根据其原始材料区分萨吉克沙拉.
- 对比的物理化学分析对于理解组成差异至关重要.
研究的目的:
- 从草药和矿物来源制备的萨吉克沙拉进行比较分析.
- 为了评估Sajjikshara两种类型的药物和分析参数.
- 为萨吉克沙拉建立质量控制基准.
主要方法:
- 萨吉克沙拉是从Fagonia cretica Linn.中准备的 (萨吉克沙拉-H) 和土壤 (萨吉克沙拉-M) 遵循传统文本.
- 物理化学,植物化学和元素分析 (Na,K,碳酸盐等) 进行了. 执行.
- 微生物负荷,亚毒素,重金属,XRD和FTIR光谱被用于全面的表征.
主要成果:
- 萨吉克沙拉两种类型都表现出类似的性pH值.
- 萨吉克沙拉-M显示了较高的灰值,酸不溶性灰和,和碳酸盐度.
- 没有污染物和碳酸盐晶体的存在由FTIR和XRD证实.
结论:
- 来自矿物质的萨吉克沙拉含有更丰富的和碳酸盐.
- 矿物来源提供了更具成本效益的制备方法.
- 标准化分析对于萨吉克沙拉的质量保证至关重要.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
293
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
293